Analgesic, Anti-Inflammatory, and Chondroprotective Activities of Siraitia grosvenorii Residual Extract

Int J Mol Sci. 2024 Apr 12;25(8):4268. doi: 10.3390/ijms25084268.

Abstract

Inflammation is crucial to osteoarthritis (OA) pathogenesis. The aim of this study was to evaluate Siraitia grosvenorii residue extract (NHGRE) obtained by extracting S. grosvenorii fruits with water as a potential food supplement for treating arthritis based on its analgesic, anti-inflammatory, and chondroprotective effects and the remaining residue with 70% ethanol. We observed the analgesic activity of NHGRE based on the acetic acid-induced writhing response in mice, examined its anti-inflammatory efficacy against carrageenan-induced paw oedema in mice, and investigated its effect on inflammatory cytokine expression in interleukin (IL)-1β-induced SW1353 cells. Furthermore, we determined its effects on cartilage protection in interleukin-1β (IL-1β)-treated SW1353 cells. NHGRE at 200 mg/kg significantly reduced the acetic acid-induced writhing response and prevented oedema formation in the carrageenan-induced paw oedema model. In IL-1β-induced SW1353 cells, NHGRE at 400 µg/mL reduced the expression of inflammation mediators such as tumour necrosis factor (TNF)-α (55.3%), IL-6 (35.4%), and prostaglandin E2 (PGE2) (36.9%) and down-regulated the expression of matrix metalloproteinase (MMP)-1 (38.6%), MMP-3 (29.3%), and MMP-13 (44.8%). Additionally, it restored degraded collagen II levels in chondrocytes. NHGRE plays a protective role in chondrocytes by regulating Nuclear factor kappa B (NF-κB) activation. Overall, NHGRE may be a useful therapeutic agent for OA by controlling pain, oedema formation, and inflammation-related mechanisms.

Keywords: NF-κB signalling pathway; Siraitia grosvenorii residue extract; anti-inflammation; chondroprotection; interleukin-1β; osteoarthritis.

MeSH terms

  • Analgesics* / pharmacology
  • Analgesics* / therapeutic use
  • Animals
  • Anti-Inflammatory Agents* / pharmacology
  • Anti-Inflammatory Agents* / therapeutic use
  • Carrageenan / adverse effects
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Cytokines / metabolism
  • Edema* / chemically induced
  • Edema* / drug therapy
  • Humans
  • Interleukin-1beta / metabolism
  • Male
  • Mice
  • Osteoarthritis / chemically induced
  • Osteoarthritis / drug therapy
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology
  • Plant Extracts* / chemistry
  • Plant Extracts* / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Plant Extracts
  • Analgesics
  • Interleukin-1beta
  • Carrageenan
  • Cytokines